| Shareholder | |||||
|---|---|---|---|---|---|
Sporos Bioventures | 6.28% | 837.64K | 2.65% | +0 | |
Solas BioVentures | 5.71% | 761.29K | 2.41% | +0 | |
Slate Path Capital LP | 5.28% | 704.12K | 2.23% | +0 | |
David TweardyCo-Founder & Scientific Advisory Board Member | 4.86% | 648.37K | 2.05% | +0 | |
Imran AlibhaiCEO & Director | 3.31% | 441.19K | 1.40% | +0 | |
Ronald DePinhoCo-Founder & Chairman of Scientific Advisory Board | 3.20% | 426.19K | 1.35% | +0 | |
Vanguard Capital Management, LLC | 2.92% | 389.09K | 1.26% | -2.49K | |
Samuel Tweardy | 2.37% | 315.66K | 1.00% | +0 | |
American Money Management Corporation | 1.68% | 223.66K | 0.71% | +0 | |
UBS Asset Management AG | 0.83% | 111.13K | 0.30% | +60.68K | |
Dan ConnCFO & Corporate Secretary | 0.80% | 107.32K | 0.34% | +0 | |
Silvercrest Asset Management Group LLC | 0.76% | 101.03K | 0.32% | +0 | |
BlackRock, Inc. | 0.72% | 95.48K | 3.42% | -292.60K | |
Renaissance Technologies LLC | 0.69% | 91.41K | 0.30% | -691.00 | |
Geode Capital Management, LLC | 0.68% | 90.35K | 1.27% | -91.99K | |
Palkon Capital Management LLC | 0.66% | 87.72K | 0.28% | +0 | |
Morgan Stanley | 0.58% | 77.73K | 0.19% | +5.25K | |
John KauhChief Medical Officer | 0.58% | 77.53K | 0.25% | +0 | |
CSL Limited | 0.51% | 68.49K | 0.22% | +0 | |
BioMatrix Partners, Ltd. | 0.50% | 67.35K | 0.21% | +0 |
